FDA Panel Backs Stronger Acetaminophen Warning Labels

WASHINGTON (MedPage Today) — A new FDA report suggests that products containing acetaminophen carry stronger label warnings about the drug’s potential for liver damage.


Read more

Related posts

Leave a Reply